EP Patent

EP0400835A1 — Substituted benzimidazoles as angiotensin II antagonists

Assigned to Merck and Co Inc · Expires 1990-12-05 · 35y expired

What this patent protects

There are disclosed new substituted benzimidazole compounds and derivatives thereof which are useful as angiotensin II antagonists. These compounds have the general formula:

USPTO Abstract

There are disclosed new substituted benzimidazole compounds and derivatives thereof which are useful as angiotensin II antagonists. These compounds have the general formula:

Drugs covered by this patent

Patent Metadata

Patent number
EP0400835A1
Jurisdiction
EP
Classification
—
Expires
1990-12-05
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.